C.M. Bidwell & Associates’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,960
Closed -$231K 543
2022
Q1
$231K Buy
6,960
+2,635
+61% +$87.5K 0.15% 129
2021
Q4
$141K Buy
+4,325
New +$141K 0.09% 215
2019
Q3
Sell
-800
Closed -$41K 473
2019
Q2
$41K Sell
800
-535
-40% -$27.4K 0.04% 258
2019
Q1
$77K Buy
+1,335
New +$77K 0.08% 205